🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Followers are urged to contact these accounts privately for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with thousands of participants share comparison images, administration instructions and claims of next-day British shipping. Sellers promote the substance there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Express Worries

However, doctors and chemists have warned that the sale of what is still an unlicensed drug in the UK is worrisome and could result in individuals injecting substances of unknown origin.

Several professionals stated the demand for the experimental drug could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Platform Reaction and Content Elimination

Based on TikTok, the service has removed violative content and banned related hashtags and query recommendations. The company stated it was committed to keeping the service secure and allocating resources in enhancing compliance measures.

Digital Trading Operations

Research also discovered groups with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, populated with images of slimming results, glowing testimonials and detailed instructions for preparing or injecting at home.

Within moments of joining one group, a vendor posted contact information, where the majority of transactions take place. The vendor sent an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.

Product Details and Costs

Within these groups, messages display black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram stated it regularly moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the research behind this drug is valid, these online products may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has already seen patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to possibly serious health risks”.